Sato, M., Nakai, Y., Nakata, W., Yoshida, T., Hatano, K., Kawashima, A., . . . Nonomura, N. (2013). EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome. Public Library of Science (PLoS).
Chicago Style (17th ed.) CitationSato, Mototaka, et al. EMMPRIN Promotes Angiogenesis, Proliferation, Invasion and Resistance to Sunitinib in Renal Cell Carcinoma, and Its Level Predicts Patient Outcome. Public Library of Science (PLoS), 2013.
MLA (8th ed.) CitationSato, Mototaka, et al. EMMPRIN Promotes Angiogenesis, Proliferation, Invasion and Resistance to Sunitinib in Renal Cell Carcinoma, and Its Level Predicts Patient Outcome. Public Library of Science (PLoS), 2013.
Warning: These citations may not always be 100% accurate.